ONE AND DONE

•  Taken only once, Xofluza stops viral replication leading to undetectable levels of virus* within 24 hours** and provides patients with flu relief within 2-3 days^{^,1,2}
•  Xofluza the first-in-class influenza antiviral in 20 years with a novel mode of action³

* Infectious virus

**In otherwise healthy patients with influenza in the CAPSTONE-1 study, Xofluza demonstrated a median time to cessation of viral shedding of 24 hours vs. 96 hours with placebo and 72 hours with oseltamivir (p<0.001 vs. both placebo and oseltamivir)

^Median time to alleviation of symptoms was 54 hours (2.3 days) with Xofluza compared with 80 hours (3.3 days) with placebo (p<0.001), in otherwise healthy patients with influenza in the CAPSTONE-1 study.